Ocean Biomedical Announces Non-Dilutive Amendment to Existing Agreement with a Key Financing Partner
October 03, 2023 14:30 ET
|
Ocean Biomedical, Inc.
Providence, RI, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA) announced today that the company and Polar Multi-Strategy Master Fund (Polar), a significant long-time...
Ocean Biomedical (NASDAQ: OCEA) Announces New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody
April 27, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Results published in peer-reviewed Cancer Research share novel insights into Chi3L1’s role in modulating Glioma stem cells and reinforces the potential therapeutic impact of Anti-Chi3L1 Providence,...
Electric Air Mobility Division of AIRO Group Holdings, Inc. and Kernel Group Holdings (NASDAQ: KRNLU) Announce Memorandum of Understanding with BLADE India
March 28, 2023 08:01 ET
|
Kernel Group Holdings, Inc
New York, NY, March 28, 2023 (GLOBE NEWSWIRE) -- Fly Blade (India) Private Limited (“BLADE India”), a joint venture between Hunch Ventures and Blade Air Mobility, Inc., and Jaunt Air Mobility LLC...
Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by Fundamental Research Corp. with a “Buy” Recommendation
March 16, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, March 16, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a next generation biopharma company, announces initiation of equity analyst coverage by Fundamental Research...
Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Equity Analyst Coverage by EF Hutton with a “Buy” Recommendation
March 14, 2023 08:01 ET
|
Ocean Biomedical, Inc.
Providence, RI, March 14, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a next generation biopharma company, announces initiation of equity analyst coverage by EF Hutton with a...